Should patients undergoing low-risk C/S receive antibiotic prophylaxis? Yes. The benefits -And cost savings - Are clear

Contemporary Ob/Gyn

Volumn 51, Issue 8, 2006, Pages 57-58

  Chelmow, David ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845767056     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Hannah ME, Hannah WJ, Hewson SA, et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 2000;356:1375-1383.
2. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2002. Natl Vital Stat Rep. 2003;52:1-113.
3. Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gynecol. 2001;184:656-661.
4. Chelmow D, Hennesy M. A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery. BJOG. 2002;109:1422-1423.
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 47, October 2003: Prophylactic Antibiotics in Labor and Delivery. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2003;102:875-882.
6. Chelmow D, Hennesy M, Evantash EG. Prophylactic antibiotics for non-laboring patients with intact membranes undergoing cesarean delivery: an economic analysis. Am J Obstet Gynecol. 2004;191:1661-1665.